Skip to main content
. Author manuscript; available in PMC: 2013 Nov 19.
Published in final edited form as: JAMA Ophthalmol. 2013 Mar;131(3):10.1001/jamaophthalmol.2013.1718. doi: 10.1001/jamaophthalmol.2013.1718

Table 3.

Linear Regression Predicting Moxifloxacin Minimum Inhibitory Concentration

Covariate Fold Increase in MIC SE 95% CI P Value
Linear Regression Predicting Moxifloxacin MIC (n = 480)
Fluoroquinolone use at presentation 2.01 1.21 1.39–2.91 <.001

Linear Regression Predicting Moxifloxacin MIC, Controlling for Organism (n = 480)
Fluoroquinolone use at presentation 1.38 0.19 0.08–0.84 .02

Linear Regression Predicting Moxifloxacin MIC by Fluoroquinolone Generation (n = 480)
Second-generation fluoroquinolone use 1.47 1.27 0.93–1.33 .10
Third-generation fluoroquinolone use 1.68 2.22 0.35–8.11 .51
Fourth-generation fluoroquinolone use 3.48 1.33 1.99–6.06 <.001

Abbreviation: MIC, minimum inhibitory concentration.